Cathie Wood’s ARK Invest Buys Over 180,000 Shares of Pfizer
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 180,000 shares of Pfizer Inc. (NYSE: PFE) on Tuesday, as the price of this fund was down over 1% in the day’s session. However, it is up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 187,746 shares of Pfizer. At Tuesday’s closing price, this would have valued this purchase at roughly $8.8 million. This is only a small fraction of the total holdings. The fund is up about 54% over the past 52 weeks.
Check out all the ARK Invest buys for Tuesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | STNE | STONECO | 31,881 |
| ARKF | Z | ZILLOW | 22,594 |
| ARKF | DSYSJ | DISCOVERY | 263,209 |
| ARKF | ETSY | ETSY | 7,712 |
| ARKF | FTCH | FARFETCH | 60,700 |
| ARKG | PSNL | PERSONALIS | 46,968 |
| ARKG | PFE | PFIZER | 187,746 |
| ARKG | NVTA | INVITAE | 261,144 |
| ARKG | RPTX | REPARE THERAPEUTICS | 71,951 |
| ARKG | SLGC | SOMALOGIC | 640,033 |
| ARKG | CRSP | CRISPR THERAPEUTICS | 23,000 |
| ARKG | VCYT | VERACYTE | 2,791 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 192,885 |
| ARKK | PD | PAGERDUTY | 140,500 |
| ARKK | NVTA | INVITAE | 88,850 |
| ARKK | FATE | FATE THERAPEUTICS | 48,314 |
| ARKQ | KMTUY | KOMATSU | 174,564 |
| ARKQ | NIU | NIU TECHNOLOGIES | 88,714 |
| ARKQ | SPFR | JAWS SPITFIRE ACQUISITION | 14,101 |
| ARKW | PD | PAGERDUTY | 54,000 |
| ARKW | SPLK | SPLUNK | 32,352 |
| ARKW | VCYT | VERACYTE | 37,000 |
| ARKW | KVSB | KHOSLA VENTURES ACQUISITION II | 235,181 |
| ARKW | ROKU | ROKU | 54,600 |
| ARKX | MKFG | MARKFORGED | 150,007 |
| ARKX | LMT | LOCKHEED MARTIN | 8,742 |
| ARKX | HEI | HEICO | 2,500 |
| ARKX | DE | DEERE | 8,084 |
| ARKX | BLDE | BLADE AIR MOBILITY | 11,216 |
| ARKX | AVAV | AEROVIRONMENT | 1,553 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
ALSO READ: Cathie Wood’s ARK Invest Sells Nearly 24,000 Shares of Boeing
Get Our Free Investment Newsletter
Source: Read Full Article
